Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary TBE Vaccination for the Elderly
NCT04573205Phase 4Unknown
- Sponsor
- Region Örebro län
- Start
- Jan 2024
- Primary completion
- Jan 2024
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Region Örebro län. Status: unknown.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT04573205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04573205.